The following terms and conditions apply to all visitors of http://www.cbapharma.com. By accessing this website, visitor acknowledges acceptance of these terms and conditions. CBA Pharma, Inc. “Company” reserves the right to change these terms and conditions from time to time at its sole discretion. By accessing the pages in this site in the future, you agree to review these terms of use to be aware of such changes, and your continued use of this site will indicate your acceptance of the terms as modified. Please read and review these terms and conditions carefully before accessing or using this website. By accessing or using this site, you acknowledge that you have read, understood and agreed to the terms of conditions. If you do not agree to the terms and conditions, you may not access or use the website.

The user of this website agrees to indemnify, defend and hold harmless the Company, its affiliates, officers, directors, employees, agents, suppliers and third party partners from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of these Terms and Conditions.

In no event shall the Company be liable for any damages (including, without limitation, damages for loss of data or profit, or due to business interruption,) arising out of the use or inability to use the materials on the Company’s website, even if the Company or a authorized representative of the Company has been notified orally or in writing of the possibility of such damage.

Forward Looking Statements

This website may contain “forward-looking statements”, within the meaning of the Private Securities Litigation Reform Act of 1995 (Section 27A of the Act and Section 21E of the Securities Exchange Act of 1934, as amended). All forward-looking statements are inherently uncertain as they are based on various expectations and assumptions concerning future events and they are subject to numerous known and unknown risks and uncertainties which could cause actual events or results to differ materially from those projected by such forward-looking statements as a result of various factors, including, without limitation, general economic trends, product demand and market acceptance, technological advances, availability of resources, domestic and foreign competition, governmental regulations and policies (including, but not limited to, changes in FDA rules, regulations and policy, as well as failure to receive marketing approval from the FDA, which would result in the inability to commercialize CBT-1® The Company disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any forward looking statements contained herein to reflect future events or developments.